glp 1 agonist drugs oral Comparing Ozempic, Wegovy and Other GLP-1 The Impact of GLP-1 Receptor

Cardiovasc Ther 2013;31:238249

Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling

The STEP-HFpEF trial randomised 529 patients with obesity (BMI 30 kg/m 2 ), HFpEF (left ventricular ejection fraction [LVEF] 45%) and New York Heart Association (NYHA) Class II symptoms to once-weekly subcutaneous semaglutide 2.4 mg or placebo

The agitation from shaking creates foam and can denature the peptide through mechanical stress

The launch of oral GLP-1s coupled with lower prices and broader access (including Medicare and Medicaid coverage in the U.S.) should drive higher utilization and market penetration as more affordable and convenient options become available. Chris Schott Senior Analyst covering the U.S

If that describes you, this is worth flagging explicitly to your doctor before any treatment decision